SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Review of the Reporting of Survival Analyses within Randomised Controlled Trials and the Implications for Meta-Analysis
5 references·4 citing·32 second hop
Review of the Reporting of Survival Analyses within Randomised Controlled Trials and the Implications for Meta-Analysis (2016)Review of the Reporting of Survival Analy…Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves (2012)Enhanced secondary analysis o…Network meta-analysis of survival data with fractional polynomials (2011)Network meta-analysis of surv…Network meta‐analysis of parametric survival curves (2010)Network meta‐analysis of para…Survival End Point Reporting in Randomized Cancer Clinical Trials: A Review of Major Journals (2008)Survival End Point Reporting …Meta‐analysis of summary survival curve data (2008)Meta‐analysis of summary surv…A Comparison of Alternative Network Meta-Analysis Methods in the Presence of Nonproportional Hazards: A Case Study in First-Line Advanced or Metastatic Renal Cell Carcinoma (2022)A Comparison of Alternative N…Synthetizing Published Evidence on Survival by Reconstruction of Patient-Level Data and Generation of a Multi-Trial Kaplan-Meier Curve (2021)Synthetizing Published Eviden…Mistakes to Avoid for Accurate and Transparent Reporting of Survival Analysis in Imaging Research (2021)Mistakes to Avoid for Accurat…GRADE Guidelines: 29. Rating the certainty in time-to-event outcomes—Study limitations due to censoring of participants with missing data in intervention studies (2020)GRADE Guidelines: 29. Rating …Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints (1998)CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010)Survival Analysis for Economic Evaluations Alongside Clinical Trials—Extrapolation with Patient-Level Data (2013)Choosing effect measures and computing estimates of effect (2019)Network meta‐analysis for indirect treatment comparisons (2002)Combination of direct and indirect evidence in mixed treatment comparisons (2004)Assessing Evidence Inconsistency in Mixed Treatment Comparisons (2006)Combining individual patient data and aggregate data in mixed treatment comparison meta‐analysis: Individual patient data may be beneficial if only for a subset of trials (2012)A process for assessing the feasibility of a network meta-analysis: a case study of everolimus in combination with hormonal therapy versus chemotherapy for advanced breast cancer (2014)Twenty years of network meta‐analysis: Continuing controversies and recent developments (2024)The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (2001)Incorporating Lag Time to Benefit Into Prevention Decisions for Older Adults (2013)Improving the Quality of Reporting of Randomized Controlled Trials (1996)Improving the quality of reporting of randomized controlled trials. The CONSORT statement (1996)Use of the CONSORT Statement and Quality of Reports of Randomized Trials (2001)Quality of Randomized Controlled Trials Reporting in the Treatment of Sarcomas (2011)Reporting of loss to follow-up information in randomised controlled trials with time-to-event outcomes: a literature survey (2011)Importance of Transparent Reporting of Health Research (2014)Primary, Secondary, and Meta-Analysis of Research (1976)Meta-analysis in clinical trials (1986)Meta‐analysis of pairs of survival curves under heterogeneity: A Poisson correlated gamma‐frailty approach (2009)Meta-analysis of effect sizes reported at multiple time points: A multivariate approach (2012)Practical methods for incorporating summary time-to-event data into meta-analysis (2007)Cochrane Handbook for Systematic Reviews of Interventions (2019)RoB 2: a revised tool for assessing risk of bias in randomised trials (2019)Reporting quality of survival analyses in medical journals still needs improvement. A minimal requirements proposal (2013)Reporting and methodological quality of survival analysis in articles published in Chinese oncology journals (2017)Meta-analysis of the literature or of individual patient data: is there a difference? (1993)IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves (2021)Application of the IPDfromKM-Shiny Method to Compare the Efficacy of Novel Treatments Aimed at the Same Disease Condition: A Report of 14 Analyses (2023)CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010)Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial (2010)
this work references cited by second hop

References

  • 2012Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves2,553 cited
  • 2011Network meta-analysis of survival data with fractional polynomials166 cited
  • 2008Survival End Point Reporting in Randomized Cancer Clinical Trials: A Review of Major Journals123 cited
  • 2010Network meta‐analysis of parametric survival curves117 cited
  • 2008Meta‐analysis of summary survival curve data88 cited

Cited by

  • 2021Synthetizing Published Evidence on Survival by Reconstruction of Patient-Level Data and Generation of a Multi-Trial Kaplan-Meier Curve31 cited
  • 2021Mistakes to Avoid for Accurate and Transparent Reporting of Survival Analysis in Imaging Research17 cited
  • 2020GRADE Guidelines: 29. Rating the certainty in time-to-event outcomes—Study limitations due to censoring of participants with missing data in intervention studies12 cited
  • 2022A Comparison of Alternative Network Meta-Analysis Methods in the Presence of Nonproportional Hazards: A Case Study in First-Line Advanced or Metastatic Renal Cell Carcinoma9 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work